Physician profile
Jon Nichols
NPI 1154391654
$2,606.38
in general payments reported to CMS, 2019-2025
22 companies · $665 in 2025
The $665 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $96.23 · 2021: $219 · 2022: $339 · 2023: $298 · 2024: $570 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,516 · Education: $17.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.78 |
| Education | $17.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,264.59 | 2019-2025 | |
| Pfizer INC. | $375.94 | 2019-2025 | |
| Braintree Laboratories, INC. | $180.42 | 2019-2025 | Sutab, Suflave |
| Novo Nordisk INC | $100.56 | 2023-2025 | Wegovy |
| Ardelyx, INC. | $99.77 | 2024-2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $76.89 | 2019-2025 | Eohilia |
| Celltrion USA INC. | $75.49 | 2024-2025 | Vegzelma, Zymfentra |
| Celgene Corporation | $61.27 | 2021-2024 | Zeposia |
| Merck Sharp & Dohme LLC | $58.13 | 2019-2024 | Dificid |
| Genzyme Corporation | $53.59 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.52 | 2023-2024 | Trulance, Xifaxan |
| Intercept Pharmaceuticals, INC. | $35.08 | 2024-2025 | |
| Medtronic, INC. | $25.48 | 2022 | |
| Gilead Sciences, INC. | $23.82 | 2021 | |
| Phathom Pharmaceuticals, INC. | $20.00 | 2025 | Voquezna |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19.56 | 2019 | |
| Ethicon US, LLC | $18.82 | 2019 | |
| Amgen INC. | $18.57 | 2023 | Amjevita, Avsola |
| Redhill Biopharma INC. | $16.22 | 2021 | |
| Shire North American Group INC | $15.28 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $14.74 | 2025 | Riteclip |
| Janssen Biotech, INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.